C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 217/20 (2006.01) A61K 31/138 (2006.01) A61P 25/24 (2006.01) C07C 217/10 (2006.01) C07C 217/16 (2006.01) C07C 217/18 (2006.01)
Patent
CA 2336962
The present invention features compounds active at both the serotonin euptake site and the N-methyl-D-aspartate (NMDA) receptor and the use of such compounds for treating different disorders. Compounds having activity at the serotonin reuptake site and the NMDA receptor ("multi-active compounds") can be used to treat different types of disorders such as depression, obsessive- compulsive disorders (OCD), sleep disorders, sexual dysfunction, and eating disorders. Preferably, the multi-active compounds are used to treat depression.
La présente invention se rapporte à des composés actifs à la fois sur le site de captage de la sérotonine et sur le récepteur N-méthyl-D-aspartate (NMDA), et à l'utilisation de ces composés dans le traitement de divers troubles. Ces composés qui déploient une activité sur le site de recaptage de la sérotonine et sur le récepteur NMDA ("composés multi-actifs") peuvent être utilisés pour traiter différents types de troubles tels que la dépression, les troubles obsessifs impulsifs, les troubles du sommeil, les dysfonctions sexuelles, et les troubles de l'alimentation. Les composés multi-actifs de l'invention sont, de préférence, utilisés dans le traitement de la dépression.
Balandrin Manuel
Moe Scott
Mueller Alan
Nps Pharmaceuticals Inc.
Smart & Biggar
LandOfFree
Methods and compounds for treating depression and other... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compounds for treating depression and other..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compounds for treating depression and other... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1689383